IPthinktank
IP ThinkTank blogIP Scorecards

Friday, December 28, 2007 4:00am — IP THINKTANK GLOBAL WEEK IN REVIEW

IP Think Tank Global Week in Review - 28 December 2007

Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet.

Highlights this week included: the WTO granting Antigua the right to infringe US copyright up to the tune of $21m, Egypt’s proposed new law for royalties on reproductions of ancient monuments and Teva’s gutsy launch of Protonix (Pantroprazole).

Please join the discussion by adding your comments on any of these stories, and please do let me know if you think we’ve missed something important, or if there is a source you think should be monitored.

You can separately subscribe to the IP Thinktank Global week in Review at http://feeds.feedburner.com/DuncanBucknellsGlobalWeekInReview

Global

Pharma

  • Patent reform: just found on pharma’s radar???: (IPBiz),
  • Sinorgchem v. International Trade Commission and Flexsys America: CAFC instructs the ITC on claim construction: (IPBiz), (Patent Prospector), (more from IPBiz)
  • Anonymised net drug sales might yet infringe - Eli Lilly & Company and Lilly Icos LLC v 8PM Chemists Ltd: (IPKat),
  • Open source for cost effective drug discovery: (Spicy IP),
  • Challenges to ethical and generic drug producers: (Profitability through simplicity),
  • US: multiple courts – same patent: a reader’s response: (Generic Pharmaceuticals & IP)
  • Avastin (Bevacizumab) - Genentech and ophthalmologists’ dispute over reformulation ban has been resolved: (Patent Docs),
  • Aricept ODT (Donepezil) - Eisai sues Mutual Pharmaceutical Co., Inc. and United Research Laboratories, Inc. claiming that its ANDA filing for Aricept ODT would infringe Eisai's composition of matter patent: (SmartBrief)
  • Effexor (Venlafaxine) - Sun Pharmaceutical Industries Ltd applies for approval to sell a drug with the same active ingredient as Wyeth’s Effexor XR, but in extended-release tablet rather than capsule: (Generic Pharmaceuticals & IP),
  • Insulin – Wockhardt’s opposition to Lilly: (Generic Pharmaceuticals & IP)
  • Lyrica (Pregabalin) - Northwestern University received $700M from Royalty Pharma for certain royalty rights to its patents covering pregabalin, a key component of Pfizer's Lyrica: (Chicago IP Litigation Blog),
  • Neupogen and Neulasta (Filgrastoim) - Sloan-Kettering Institute for Cancer Research has filed a lawsuit against Amgen, claiming the drugmaker underpaid royalties on the two drugs: (SmartBrief),
  • Omeprazole (Losec / Prilosec) – Astra’s patent application for omeprazole formulation rejected by Indian Patent Office (Generic Pharmaceuticals & IP),
  • Protonix (Pantroprazole) - Teva Pharmaceutical Industries Ltd. has launched a generic version of the heartburn pill some 2½ years before Wyeth’s U.S. patent  is set to expire in July 2010: (The IP Factor), (Generic Pharmaceuticals & IP)
  • Tarceva (Erlotinib) – Thailand’s proposed compulsory licence: (Generic Pharmaceuticals & IP),

Australia

Canada

China

  • China trade mark law: simple and effective: (China Law Blog),

  • Yahoo China loses copyright suit for online music search: (TG Daily)

Egypt

Europe

  • Discussion of the Lisbon Treaty amending the Treaty on European Union and the Treaty establishing the European Community: (IPKat),
  • EPO has announced a punitive fee schedule effective April 1, 2009, that will punish applicants filing more than 15 claims in an application: (IPKat), (IPEG),
  • New European duties expected for trade mark royalties and license fees: (IP Updates),
  • ‘Must fit’ invalidates Community design: (IP Updates)

India

  • Indian Patent Office receives ISA & IPEA recognition: (Competitive info),
  • Moser Baer’s pricing strategy: The new anti-piracy model?: (Spicy IP),
  • Petition to increase transparency at the Indian Patent Office: (Spicy IP),
  • Copyright, music licenses and New Year parties: (Spicy IP)

Ireland

  • Dunnes Stores has lost its bitterly-contested design dispute against UK-based fashionistas Mosaic Fashions: (IPKat), (Counterfeit Chic)

United Kingdom

  • Nokia v InterDigital: High Court rules on essentiality of patents under 3G standard (IPKat), (IPEG), (Stockhouse)
  • Experience Hendrix LLC & Anor v Times Newspapers Ltd: Times given more time to gather evidence to defend copyright infringement claims: (IPKat)
  • A pub landlady has lost her High Court battle over using a foreign broadcaster to show live English Premier League football matches to her customers: (ITN)

United States

 

  • AT&T – Vonage to settle with AT&T in patent infringement dispute: (Ars Technica),
  • eBay - US District Court finds eBay intentionally violated MercExchange's patent: (Mondaq),
  • Fairchild Semiconductor Corp – Delaware District Judge finds that patentee had contracted away the right to sue defendant, Power Integrations Inc.: (Delaware IP Law Blog)
  • Google – US Appeals Court partially upholds, partially vacates summary judgment in patent dispute between Hyperphase and Google: (Patent Prospector), (Philip Brooks),
  • Illumina – USPTO orders re-examination of two patents included in the patent litigation between Illumina and Affymetrix: (Yahoo Canada Finance), (RTT News),
  • iRobot Corp. - iRobot wins patent suits against former employee Jameel Ahed and his company, Robotic FX, Inc.: (Fox Business), (Business Week),
  • Marriott - Third Circuit considering how to analyse false celebrity endorsement claims under the Lanham Act in Lewis v Marriott International Inc.: (43(B)log)
  • Qwest Communications – Qwest settles patent litigation with Ronald A. Katz Technology: (Philip Brooks)
  • Van Cleef & Arpels - Heidi Klum and Mouawad sued for infringement of Van Cleef &Arpels’ four-leaf clover jewellery design: (Counterfeit Chic),
  • Yahoo – Ars submits prior art for Yahoo’s ‘smart drag-and-drop’ patent application using peer-to-patent system: (Ars Technica)

Post a Comment | Permalink | + del.icio.us


0 Comments


0 Trackbacks

trackback url: http://duncanbucknell.com/trackback.php?id=221

CONTACTSUBSCRIBE